Heparin sodium and Vasculitis - a phase IV clinical study of FDA data

Summary:

Vasculitis is reported as a side effect among people who take Heparin sodium (heparin sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Constipation.

The phase IV clinical study analyzes which people have Vasculitis when taking Heparin sodium. It is created by eHealthMe based on reports of 20,987 people who have side effects when taking Heparin sodium from the FDA, and is updated regularly.

What is Heparin sodium?

Heparin sodium has active ingredients of heparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 21,065 Heparin sodium users. Check the latest studies of Heparin sodium.

What is Vasculitis?

Vasculitis (inflammation of a blood vessel or blood vessels) is found to be associated with 968 drugs and 1,215 conditions by eHealthMe. Check the latest studies of Vasculitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

20,987 people reported to have side effects when taking Heparin sodium.
Among them, 29 people (0.14%) have Vasculitis.

Among these 29 people:

How long have people been on Heparin sodium when they have Vasculitis? *

What is the gender of people who have Vasculitis when taking Heparin sodium? *

female: 67.86 %
male: 32.14 %

What is the age of people who have Vasculitis when taking Heparin sodium? *

What are other drugs people take besides Heparin sodium? *

What are other side effects people have besides Vasculitis? *

Hypotension (abnormally low blood pressure): 16 people, 55.17%
Pneumonia: 12 people, 41.38%
Dyspnea (difficult or laboured breathing): 10 people, 34.48%
White Blood Cell Count Decreased: 9 people, 31.03%
Dizziness: 7 people, 24.14%
Necrosis (the death of body tissue): 7 people, 24.14%
C-Reactive Protein Increased: 6 people, 20.69%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 20.69%
Itching: 6 people, 20.69%
Renal Artery Stenosis (narrowing of renal artery): 6 people, 20.69%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 17.24%
Constipation: 5 people, 17.24%
Temporomandibular Joint Syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress): 4 people, 13.79%
Fibrin Degradation Products Increased: 4 people, 13.79%
Joint Pain: 4 people, 13.79%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 3 people, 10.34%
Aortitis (inflammation of the aortic wall): 3 people, 10.34%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 6.90%
Pseudomembranous Colitis (antibiotic-associated diarrhoea (aad), is an infection of the colon): 1 person, 3.45%
Stable Angina (a constant chest pain): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Heparin sodium and have Vasculitis?

- Check whether Vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Heparin sodium:

Heparin sodium (21,065 reports)

Vasculitis treatments and more:

Vasculitis (18,555 reports)

Browse all side effects of Heparin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vasculitis:

Vasculitis (968 drugs)

Browse all the conditions that are associated with Vasculitis:

Vasculitis (1,215 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on heparin sodium (the active ingredients of Heparin sodium) and Heparin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.